Top

National Cervical Cancer Screening Program

31 January 2018


Routine cervical screening is not recommended in the renewed program for women under 25 years. Some women under 25 will present with an expectation for routine screening, having had previous Pap tests. It is important that these women are aware that Medicare does not fund routine HPV cervical screening tests in women under 25.

Pathology laboratories are reporting that a significant number of samples are being submitted from women under 25 years of age. Given Medicare does not fund routine HPV cervical screening tests in women under 25 these will either need to be privately funded by the patient or, with the consent of the referring practitioner, not be processed by the laboratory. For further information, access the latest National Cervical Screening Program Newsflash.



MEDIA CENTRE

News

Dr Pieter Mourik (AM)

Being recognised in the Australia Day honours was a highlight for this rural medicine advocate.
 

20/09/2021

News

RANZCOG urges all practitioners to help pregnant women get vaccinated

RANZCOG urges all practitioners to heed the advice issued by RANZCOG and ATAGI which recommends that pregnant women are routinely offered Pfizer or Moderna mRNA vaccine at any stage of pregnancy.

17/09/2021

News

EOI: eLearning content reviewers

As women’s healthcare evolves rapidly, RANZCOG is keen to ensure its eLearning programs and modules meet member expectations and education standards.

13/09/2021